SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Molina Healthcare, Inc. (MOH)

NEW YORK, May 1, 2018 /PRNewswire/ -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/moh.

The investigation concerns whether Molina and certain of its officers and/or directors have violated federal securities laws.

On April 28, 2016, Molina reported that it had missed its earnings targets for the quarter ended March 31, 2016 and sharply cut full-year 2016 earnings guidance, citing higher costs tied to administrative capacity issues.  On this news, Molina's share price fell $12.46, or 19..4%, to close at $51.76 on April 29, 2016.  On February 15, 2017, Molina announced its financial and operating results for the quarter and year ended December 31, 2016, advising investors that the Company could not commit to Affordable Care Act ("ACA") Health Exchange participation beyond 2017.  On this news, Molina's share price fell $10.71, or 17.88%, to close at $49.18 on February 16, 2017.  Then, on August 2, 2017, Molina announced its financial and operating results for the quarter ended June 30, 2017, reporting a net loss of $230 million for the quarter, termination of its ACA Health Exchange participation in Utah and Wisconsin, and a major restructuring plan.  During the Company's related earnings call, Molina disclosed to investors that its administrative infrastructure was inadequate to sustain Molina's rapid growth.  On this news, Molina's share price fell $3.92, or 5.92%, to close at $62.32 on August 3, 2017.

If you are aware of any facts relating to this investigation, or purchased Molina shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/moh.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

View original content with multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-molina-healthcare-inc-moh-300640298.html

SOURCE Bronstein, Gewirtz & Grossman, LLC